By Newsbreak Producer Hoosen Ebrahim - A new HIV cure trial spearheaded by the University of KwaZulu-Natal (UKZN) is already showing early signs of positive outcomes. The trial in its early stages has shown 20% of participants remain off anti-retroviral therapy (ART) and are virally suppressed after one-and-a-half years. Led by academic medical leaders, it tested an innovative combination immunotherapy approach aimed at reducing or eliminating hidden traces of HIV in the body. Researchers say these results provide insights toward the development of future HIV cure approaches...